5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer susceptibility mutations in patients with urothelial malignancies
    Journal Article

    Carlo, M. I.; Ravichandran, V.; Srinavasan, P.; Bandlamudi, C.; Kemel, Y.; Ceyhan-Birsoy, O.; Mukherjee, S.; Mandelker, D.; Chaim, J.; Knezevic, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • The association between small primary tumor size and prognosis in metastatic renal cell carcinoma: Insights from two independent cohorts of patients who underwent cytoreductive nephrectomy
    Journal Article

    DiNatale, R. G.; Xie, W.; Becerra, M. F.; Silagy, A. W.; Attalla, K.; Sanchez, A.; Mano, R.; Marcon, J.; Blum, K. A.; Benfante, N. E.; more...
    European Urology Oncology (2020)

    Fulltext@MSK | Save
  • Driver mutations in acute myeloid leukemia
    Review

    Kishtagari, A.; Levine, R. L.; Viny, A. D.
    Current Opinion in Hematology (2020)

    Fulltext@MSK | Save
  • Therapeuticstargeting the gut microbiome: Rigorous pipelines for drug development
    Editorial

    Markey, K. A.; van den Brink, M. R. M.; Peled, J. U.
    Cell Host & Microbe (2020)

    Fulltext@MSK | Save
  • Efficacy and determinants of response to HER kinase inhibition in HER2-mutant metastatic breast cancer
    Journal Article

    Smyth, L. M.; Piha-Paul, S. A.; Won, H. H.; Schram, A. M.; Saura, C.; Loi, S.; Lu, J.; Shapiro, G. I.; Juric, D.; Mayer, I. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
    Journal Article

    Yue, L.; Sharma, V.; Horvat, N. P.; Akuffo, A. A.; Beatty, M. S.; Murdun, C.; Colin, C.; Billington, J. M. R.; Goodheart, W. E.; Sahakian, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Morphologic and immunohistochemical assessment of CDH1 loss of function alterations in prostatic adenocarcinoma
    Research Letter

    Gupta, S.; Fine, S. W.; Chang, J.; Tickoo, S. K.; Chen, Y. B.; Al-Ahmadie, H. A.; Sirintrapun, S. J.; Abida, W.; Ladanyi, M.; Reuter, V. E.; more...
    American Journal of Surgical Pathology (2020)

    Fulltext@MSK | Save
  • The KRAS(G12C) inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients
    Journal Article

    Hallin, J.; Engstrom, L. D.; Hargis, L.; Calinisan, A.; Aranda, R.; Briere, D. M.; Sudhakar, N.; Bowcut, V.; Baer, B. R.; Ballard, J. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save